Alison Bladh

OCTOBER 25, 2024

Boost Your Health and Skin with Collagen During Menopause As we navigate the natural changes of menopause, supporting our body becomes more essential than ever. Collagen, a protein our bodies produce less of over time, plays a critical role in skin elasticity, joint health, and bone density. In fact, collagen supplements can be a powerful addition to your wellness routine, especially for women in their 40s and beyond.

Collagen 102

Collagen Vitamin C Skin Health Consultation 102

Skin Inc

OCTOBER 25, 2024

Their trends team has been analyzing the wellness space and upcoming trends for more than 20 years. Here are the trends that GWS noticed took priority in 2024, and will revolutionize wellness for 2025 and beyond.

52

52

Dermatology Times

OCTOBER 25, 2024

Shawn Kwatra, MD, reviews key highlights of his sessions at Fall Clinical 2024 on the latest updates in itch conditions.

Dermatitis 45

Dermatitis Clinic 45

US Dermatologt Partners

OCTOBER 25, 2024

Chillicothe, Missouri – U.S. Dermatology Partners physician, Dr. Megan Lent , is named Best Dermatologist in the Chillicothe Constitution-Tribune’s Reader’s Choice Awards 2024! U.S. Dermatology Partners is Recognized in the Chillicothe Constitution-Tribune’s 2024 Reader’s Choice Awards U.S. Dermatology Partners is thrilled to congratulate Dr.

Dermatology 41

Dermatology Networking Surgery Clinic 41

Dermatology Times

OCTOBER 25, 2024

Phase 3b study showed promise in clearing moderate PsO in sensitive areas for patients unresponsive to topical treatments.

Treatments 45

Treatments 45

The Dermatology Digest

OCTOBER 25, 2024

As National Eczema Awareness Month 2024 draws to a close, TDD/JDNPPA sat down with Kristin Belleson, the new President and CEO of the National Eczema Association (NEA), to discuss the group’s upcoming education and advocacy initiatives, learn how healthcare providers can be more involved with the NEA, and get some intel on the coveted NEA Seal of Acceptance program.

Eczema 36

Eczema Education Makeup Office 36

Aesthetic Advancements Institute (AAI)

OCTOBER 25, 2024

As a practitioner in the field of medical aesthetics, staying ahead of trends is crucial for delivering the best outcomes for our patients. One of the most significant shifts we’re witnessing is the rise of biostimulatory injectables. These innovative treatments not only enhance our toolkit but also redefine how we approach skin rejuvenation, focusing on long-term skin health alongside immediate results.

Injections 36

Injections Social Media Collagen Skin Health 36

Dermatology Times

OCTOBER 25, 2024

Catch up on coverage from the second day of the 2024 Fall Clinical Dermatology Conference in Las Vegas, Nevada.

Clinic 36

Clinic Dermatology 36

The Dermatology Digest

OCTOBER 25, 2024

Deuruxolitinib (Leqselvi, Sun Pharma) shows ongoing and clinically meaningful improvements for up to 68 weeks in scalp hair regrowth among alopecia areata patients, according to pooled long-term results from open-label extension presented at the 2024 Fall Clinical Dermatology Conference in Las Vegas, NV. The U.S. Food and Drug Administration approved deuruxolitinib (8mg) tablets for the treatment of adults with severe AA earlier this year.

Clinic 36

Clinic Sustainability Tools Dermatology 36

Dermatology Times

OCTOBER 25, 2024

Shahriari highlighted advanced dermatology treatments, clinical trial inclusivity, and key care strategies for complex skin conditions at Fall Clinical 2024.

Innovations 36

Innovations Clinic Dermatology Treatments 36

The Dermatology Digest

OCTOBER 25, 2024

Sherrif F. Ibrahim, MD, PhD, an Assistant Professor in the Department of Dermatology at the University of Rochester Medical Center in Rochester, NY, shares his enthusiasm for Sciton’s BBL HEROic , a workhorse broadband light device that he uses to address pigmentation, vascularity, and skin quality on the face, chest, and arms. The post Devices Dermatologists Love Episode Three: Sciton’s BBL HEROic With Dr.

Dermatology 36

Dermatology Medical 36

Dermatology Times

OCTOBER 25, 2024

Del Rosso reviews available and upcoming monoclonal antibodies, including nemolizumab, lebrikizumab, bimekizumab, and more.

Dermatology 36

Dermatology 36

Dermatology Times

OCTOBER 25, 2024

This review of the latest dermatologic studies includes discussions on the development of the Hand Eczema Impact Scale, the role of tofacitinib on Th1 and Th2 cytokines, and more.

Eczema 36

Eczema Dermatology 36